KNOWLEDGE BANK

Interviews

Merck

Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshooting and technical training for downstream processes Chan holds a degree in Chemical Engineering from the National University of Singapore

Articles

The Past, Present, and Future of Sickle-cell Disease Registries: Findings from a Global Review

Patient registries are important tools in the healthcare system for systematically collecting data over time from a population living with a certain disease condition or exposure Welldesigned and wellexecuted patient registries hold great potential in providing important disease insights into for example patient characteristics patterns of treatment and care

Research Insights

Transcriptome and Machine Learning Analysis of the Impact of COVID-19 on Mitochondria and Multiorgan Damage

The effects of coronavirus disease primarily concern the respiratory tract and lungs however studies have shown that all organs are susceptible to infection by severe acute respiratory syndrome coronavirus

Case Studies

Open Innovation in Pharmaceutical Industry: A Case Study by Eli Lilly

Abstract Interest on Open Innovation paradigm has seen a phenomenal increase since last two decades especially when Henry Chesbrough coined this term in triggering the creation of a new whole body of knowledge However all of his research work could not come up with a standardized allinone theory Instead we find a heterogeneous series of models tha

Techno Trends

University of Florida’s Prometheon Pharma Launches Indiegogo Campaign for Needle-Free, Temperature Stable Insulin Patch Innovation

The University of Floridas Prometheon Pharma has launched a milliondollar Indiegogo campaign to advance development of its groundbreaking needlefree temperature stable insulin patches Needlefree patches developed by former faculty at UF and Harvard Medical School Stephen Hsu MDPhD Prometheon Pharma will replace billions of painful needle injections every year

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Moving from Code to Consequence

Dr. Sanjesh Kumar

Dr. Sanjesh Kumar is an Assistant Professor at Chandigarh University Uttar Pradesh with a Ph.D. in Pharmacology. An award-winning academician specialized in neurodegenerative disorders and advanced drug delivery, he has authored over 45 high-impact publications and holds multiple patents, seamlessly bridging the gap between clinical research and classroom education.

Dr. Disha Marwaha

Dr. Disha Marwaha earned a Ph.D. in Biological Sciences from the CSIR-Central Drug Research Institute (CSIR-CDRI) in 2024 and currently serves as an Assistant Professor at Chandigarh University Uttar Pradesh. Her research encompasses nanomedicine, pharmacokinetics, formulation development, and targeted drug delivery systems. She has authored more than 22 articles in peer-reviewed international journals.

2

Innovative Tool For Drug Design And Development

Subash Senthil

S.Subash awarded 2 best poster presentation awards and secured 1st place in Poster presentation. I published three articles in national and international peer reviewed journal. And, also attend many conferences to upgrade knowledge.

 

3

Artificial Intelligence

Mansi Athalye

Assistant Professor, Department of Pharmaceutics, L. M.College of Pharmacy

Daryai Uma Ghanshyam

L. M.College of Pharmacy

4

Reshaping the Clinical Trial Model

Anna Hayes

Anna Hayes is a senior data management leader (At Veramed) with nearly 20 years of experience in clinical research. She specializes in biometrics strategy, innovation, and operational excellence, driving smarter oversight and data-driven trial execution. Anna is passionate about integrating people, processes, and technology to future-proof clinical trials and elevate data quality.

5

How Big Data is Transforming Clinical Trials in Asia

Atharva

I’m Atharva, a content writer currently at Consegic Business Intelligence. With over 3 years of professional experience, I've specialised as a ghostwriter for prominent companies and industry publications, exploring various topics.

press releasesRead more...

ProBio Enters Exclusive Global Licensing Agreement with AbTis to Develop Next-Generation ADC Asset

ProBio a global contract research development and manufacturing organization CRDMO today announced that it has entered into an exclusive global licensing agreement with AbTis Co Ltd

AGC Biologics partners with Child’s Cure Genetic Research to pursue mRNA-based therapeutic for severe epileptic disorder

In a world where patients with CDKL deficiencies can suffer to epileptic seizures a day a contract biopharmaceutical manufacturer and a parentfounded foundation will partner on earlystage

Rakovina Therapeutics Secures Exclusive Worldwide Licence to Artemis.AI™ Platform for DNA-Damage Response Oncology Drug Discovery

Rakovina Therapeutics Inc TSXV RKV FSE JO OTCMKTS RKVTF a biopharmaceutical company advancing innovative cancer therapies through AIpowered drug discovery today announced

Roche opens up new possibilities for genomic research in Asia Pacific with next-generation sequencing technology

Roche is advancing its nextgeneration sequencing NGS ambitions in Asia Pacific following the global launch of AXELIOS in June Building on early adoption in South Korea Roche will bring the transformative technology closer to researchers and laboratory leaders across the region through AXELIOS Days

Charles River Laboratories to Acquire Frontage’s Bioanalysis and DMPK Businesses

Charles River Laboratories International Inc announced today that it has entered into definitive agreements to acquire Frontage Holdings Corporations bioanalysis and DMPK operations in Exton Pennsylvania for approximately million in cash subject to customary closing adjustments In addition to the i...

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

AI can generate protein candidates at an unprecedented speed but experimental validation remains essential to determine whether they properly express bind targets and demonstrate the desired biological properties Sino Biological Inc Shenzhen Stock Exchange SZ a global leader in recombinant protein t...

EventsRead more...

09 - 11

Nov 2026

11th Microbiome Movement USA Summit

The Colonnade Hotel, Boston, M...

10 - 11

Nov 2026

Extractables & Leachables Europe

Parkhotel Schӧnbrunn, Vienna,...

11 - 13

Nov 2026

Frontiers in Cancer Science 2026

One Farrer Hotel,1 Farrer Park...

11 - 12

Nov 2026

24 - 27

Nov 2026

Pharmtech & Ingredients 2026

Crocus Expo, Pavilion 2, Mosco...

24 - 25

Nov 2026

BioPharma Deals Conference 2026

Science Congress Center, Munic...

26 - 28

Nov 2026

One Health Conference 2026

Thapar Institute of Engineerin...

LATEST NEWSRead more...

Shionogi Enters into Licence Agreement with Link for Antibiotic Cefiderocol

Shionogi has entered into a licence agreement with Link Healthcare Singapore to develop and commercialise cefiderocol in Singapore and Malaysia

IDEL Therapeutics Partners with Daiichi Sankyo to Develop Multi-Drug Conjugates for Solid Tumours

IDEL Therapeutics has entered into a global research collaboration with Daiichi Sankyo to evaluate a multidrug conjugate MDC using iDELs synthetic shuttle platform for the treatment of selected solid tumours The multiyear collaboration will focus on the preclinical evaluation of a new class of MDCs...

Bayer’s Asundexian Receives Approval for Secondary Stroke Prevention

Bayer has received approval from the US Food and Drug Administration FDA for asundexian mg tablets marketed under the brand name Sunharbo to reduce the risk of recurrent stroke in adults following a recent noncardioembolic ischaemic stroke or highrisk transient ischaemic attack TIA

Johnson & Johnson Receives Approval for RYBREVANT FASPRO to Treat Advanced Head and Neck Cancer

Johnson Johnson has received accelerated approval from the US Food and Drug Administration FDA for RYBREVANT FASPRO amivantamab and hyaluronidaselpuj to treat adults with recurrent or metastatic head and neck squamous cell carcinoma HNSCC

Boehringer Ingelheim Enters into Partnership with SBP Group to Advance Next-Generation Cancer Therapies

Boehringer Ingelheim and Sino Biopharmaceutical SBP Group have entered into a multiprogram partnership to develop potential nextgeneration cancer treatments using antibodydrug conjugate ADC and Tcell engager TcE technologies

MindWalk Partners with Teva to Support Antibody Discovery Using AI

MindWalk has entered into a multiyear agreement with Teva Pharmaceuticals Australia to support antibody discovery and design optimisation using AI technology ReefIQ is MindWalks biological context platform for the life sciences sector powered by its HYFT technology The technology